Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up
Stock Investor Wire

CLSD Quote, Trading Chart, Clearside Biomedical Inc.


home / stock / clsd / clsd quote

$3.25 Last:

-6.88% Change Percent:

$3.49 Open:

$3.25 Previous Close:

$3.56 High:

$3.18 Low:

490,951 Volume:

02/25/2021 04:55:23 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Last Five Trading Days

Stock DateOpen PriceClose PriceHighLowVolume
2021-02-253.493.253.563.18490,951
2021-02-243.533.493.713.46188,242
2021-02-233.753.53.853.03814,516
2021-02-223.933.84.253.8506,118
2021-02-193.483.854.033.4255679,894
2021-02-183.623.473.633.3410,346
2021-02-173.863.583.863.54376,600
2021-02-163.853.864.23.81444,384
2021-02-153.93.833.913.75309,018
2021-02-123.93.833.913.75308,912
2021-02-114.253.864.343.7866,482
2021-02-1044.254.533.8231,395,349
2021-02-093.843.894.013.77603,526
2021-02-083.473.824.05733.41,016,103
2021-02-053.53.43.553.26389,095
2021-02-043.593.53.593.38254,744
2021-02-033.553.513.593.35503,696
2021-02-023.123.253.263.07430,058
2021-02-013.073.073.17782.97788,599
2021-01-293.313.133.443.11424,592
Stock Information

Clearside Biomedical Inc. Company Name:

CLSD Stock Symbol:

NASDAQ Market:

Clearside Biomedical Inc. Website:

CLSD Quote, Trading Chart, Clearside Biomedical Inc.

MENU
CLSD CLSD Quote CLSD Short CLSD News CLSD Articles CLSD Message Board
Get CLSD Alerts

News, Short Squeeze, Breakout and More Instantly...

Stock Investor Wire
RECENT CLSD NEWS
  • CLSD - Clearside Biomedical Featured in Multiple Data Presentations at the 44th Virtual Annual Macula Society Meeting

    - Proprietary suprachoroidal injection platform demonstrates broad applicability across multiple retinal disorders - - CLS-AX will also be featured at the upcoming virtual Angiogenesis, Exudation, and Degeneration 2021 conference on February 13, 2021 - ALPHARETTA, ...

  • CLSD - Clearside Biomedical Announces First Patients Enrolled in Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) for the Treatment of Wet AMD

    ALPHARETTA, Ga., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that the first p...

  • CLSD - Clearside Biomedical Announces Pricing of $12 Million Registered Direct Offering

    ALPHARETTA, Ga., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that it has ente...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your Twitter Account

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.


Sign up or login to continue

Sign up or login to continue.


Forgot password?




WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Member Benefits

Member Coins


Log In

Sign Up

Stay Connected
Follow @marketWN

Contact

Privacy

Terms of Service

Disclaimer

© 2020 Market Wire News